It took years to understand why my mastectomy site looked different. Knowing I healed correctly for my procedure helped me ...

A cancer thriver reflects on the emotional toll, survivorship, advocacy and support networks they wish they’d known at ...

New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with ...

I’ve survived rare blood cancer for 15 years, but the lasting side effects have taken a toll — even so, I still find purpose, ...

The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in ...

The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.

Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit ...

The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.

Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to ...

Dr. Joshua Sabari and Dr. Nausheen Ahmed sat down to discuss topline takeaways in the realm of hematologic malignancies following the 2025 ASCO Meeting.